Nucleoside reverse transcriptase inhibitors (NRTIs)

H 1 Pill - white round

Pill with imprint H 1 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Camber Pharmaceuticals, Inc.

Zidovudine is used in the treatment of Reduction of Perinatal Transmission of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Zidovudine (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-H 1-300 mg-White-Round
Zidovudine (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-H 1-300 mg-White-Round
Zidovudine (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-H 1-300 mg-White-Round

Zidovudine (oral/injection)
Generic Name: zidovudine (oral/injection) [ zye-doe-vyoo-deen ]
Imprint: H 1
Strength: 300 mg
Color: White
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 31722-0509
Inactive Ingredients: Microcrystalline cellulose, Sodium starch glycolate type A potato, Magnesium stearate, Hypromelloses, Polyethylene glycol, Titanium dioxide,
Latest News
Related Drugs